Naturhouse Health First Half 2024 Earnings: EPS: €0.097 (vs €0.12 in 1H 2023)

Naturhouse Health (BME:NTH) First Half 2024 Results

Key Financial Results

• Revenue: €28.0m (down 1.8% from 1H 2023).
• Net income: €5.83m (down 21% from 1H 2023).
• Profit margin: 21% (down from 26% in 1H 2023). The decrease in margin was primarily driven by higher expenses.
• EPS: €0.097 (down from €0.12 in 1H 2023).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Naturhouse Health Earnings Insights

Looking ahead, revenue is forecast to grow 2.0% p.a. on average during the next 3 years, compared to a 6.6% growth forecast for the Specialty Retail industry in Europe.

Performance of the market in Spain.

The company's share price is broadly unchanged from a week ago.

Risk Analysis

You should always think about risks. Case in point, we've spotted 2 warning signs for Naturhouse Health you should be aware of, and 1 of them doesn't sit too well with us.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.